Orphan Drug Act

Results: 190



#Item
121Rare disease / Health / Biotechnology / Medicine / Orphan Drug Act / Pharmaceuticals policy / Drug discovery / Orphan drug

DOC Document

Add to Reading List

Source URL: icord.se

Language: English - Date: 2007-03-26 08:20:12
122Tuesday, May 20 Capital Hilton • 1001 16th Street, NW 07:30 REGISTRATION Sessions I-VII in Conjunction with the National Organization

Tuesday, May 20 Capital Hilton • 1001 16th Street, NW 07:30 REGISTRATION Sessions I-VII in Conjunction with the National Organization

Add to Reading List

Source URL: icord.se

Language: English - Date: 2008-09-08 16:06:57
123Programme Overview ICORD 2006 International Conference on Rare Diseases and Orphan Drugs In association with European Platform for Patients’ Organizations, Science and Industry (EPPOSI) Madrid, Spain, October 25, 2006

Programme Overview ICORD 2006 International Conference on Rare Diseases and Orphan Drugs In association with European Platform for Patients’ Organizations, Science and Industry (EPPOSI) Madrid, Spain, October 25, 2006

Add to Reading List

Source URL: icord.se

Language: English - Date: 2007-03-26 08:20:12
124Microsoft Word - FINAL Call for Tender CAVOD 19Mar10.doc

Microsoft Word - FINAL Call for Tender CAVOD 19Mar10.doc

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2010-08-30 05:25:41
125Microsoft Word - ICORD2012 Report

Microsoft Word - ICORD2012 Report

Add to Reading List

Source URL: icord.se

Language: English - Date: 2012-10-01 09:45:05
126

PDF Document

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2014-07-31 15:40:11
127August 30, 2013 The Honorable David B. McKinley 412 Cannon House Office Building Washington, DC[removed]Dear Mr. McKinley: On behalf of the 30 million men, women and children in the U.S. affected by the estimated 7,300 kno

August 30, 2013 The Honorable David B. McKinley 412 Cannon House Office Building Washington, DC[removed]Dear Mr. McKinley: On behalf of the 30 million men, women and children in the U.S. affected by the estimated 7,300 kno

Add to Reading List

Source URL: www.rarediseases.org

Language: English - Date: 2013-09-26 15:17:12
128

PDF Document

Add to Reading List

Source URL: pluristem.com

Language: English - Date: 2013-12-24 07:18:09
129

PDF Document

Add to Reading List

Source URL: www.pluristem.com

Language: English - Date: 2013-12-24 07:18:09
130Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Bo

Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Bo

Add to Reading List

Source URL: www.rarediseases.org

Language: English - Date: 2012-12-18 11:57:21